Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Ignyte Acquisition Corp

PKBO
Current price
0.07 USD 0 USD (0.00%)
Last closed 0.07 USD
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange PINK
Capitalization 1 618 743 USD
Yield for 12 month -12.39 %
1Y
3Y
5Y
10Y
15Y
PKBO
21.11.2021 - 28.11.2021

Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of patients with cancer, inflammatory, and rare diseases in the United States. The company's lead product candidate is PHP-303, which is in Phase 2 clinical study for the treatment of alpha-1 antitrypsin deficiency and acute respiratory distress syndrome. It also develops Trop2 PH1, an antibody-drug-conjugate in preclinical trials for solid tumors. Peak Bio, Inc. is based in Pleasanton, California. Address: 4900 Hopyard Road, Pleasanton, CA, United States, 94588

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

15 USD

P/E ratio

Dividend Yield

Current Year

Last Year

+607 681 USD

Current Quarter

+75 192 USD

Last Quarter

+278 831 USD

Current Year

Last Year

+607 572 USD

Current Quarter

+75 175 USD

Last Quarter

+278 798 USD

Key Figures PKBO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -6 652 362 USD
Operating Margin TTM -1913.08 %
PE Ratio
Return On Assets TTM -262.12 %
PEG Ratio
Return On Equity TTM
Wall Street Target Price 15 USD
Revenue TTM 354 023 USD
Book Value -0.98 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -71.2 %
Dividend Yield
Gross Profit TTM -3 316 572 USD
Earnings per share -0.18 USD
Diluted Eps TTM -0.18 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics PKBO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History PKBO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation PKBO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 16.2527
Price Sales TTM 4.5724
Enterprise Value EBITDA -0.382
Price Book MRQ

Financials PKBO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PKBO

For 52 weeks

0.002 USD 0.27 USD
50 Day MA 0.091 USD
Shares Short Prior Month 43 900
200 Day MA 0.032 USD
Short Ratio 0.35
Shares Short 29 055
Short Percent